NCT04328844 2026-03-30A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic CancersiOncturaPhase 1 Active not recruiting210 enrolled
NCT03013218 2025-08-01A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)ALX Oncology Inc.Phase 1 Completed174 enrolled
NCT01655225 2022-04-08A Study of LY3023414 in Participants With Advanced CancerEli Lilly and CompanyPhase 1 Completed156 enrolled
NCT03027284 2020-05-19A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic CancerEli Lilly and CompanyPhase 1 Completed19 enrolled
NCT00004189 2013-02-11Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced CancerNational Cancer Institute (NCI)Phase 1 Completed40 enrolled
NCT00004086 2009-06-09Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell CancerNational Cancer Institute (NCI)Phase 1 Unknown